USD 0.89
(7.23%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -69.79 Million USD | 85.84% |
2022 | -493.04 Million USD | 36.95% |
2021 | -782.02 Million USD | -262325.5% |
2020 | -298 Thousand USD | -103.06% |
2019 | 9.74 Million USD | 119.97% |
2018 | -48.81 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -14.65 Million USD | -160.55% |
2024 Q3 | -33.81 Million USD | -805.33% |
2024 Q2 | -3.73 Million USD | 74.51% |
2023 Q4 | -5.62 Million USD | 63.0% |
2023 FY | -69.79 Million USD | 85.84% |
2023 Q3 | -15.19 Million USD | 33.07% |
2023 Q2 | -22.7 Million USD | 9.94% |
2023 Q1 | -25.21 Million USD | 75.38% |
2022 Q1 | -138.22 Million USD | -1682.22% |
2022 Q2 | -135.72 Million USD | 1.81% |
2022 FY | -493.04 Million USD | 36.95% |
2022 Q4 | -102.4 Million USD | 12.24% |
2022 Q3 | -116.69 Million USD | 14.02% |
2021 FY | -782.02 Million USD | -262325.5% |
2021 Q4 | 8.73 Million USD | 102.68% |
2021 Q3 | -325.65 Million USD | -5793.14% |
2021 Q2 | -5.52 Million USD | 71.11% |
2021 Q1 | -19.12 Million USD | -1689.94% |
2020 Q4 | 1.2 Million USD | 1003.67% |
2020 Q2 | 2.74 Million USD | 129.05% |
2020 FY | -298 Thousand USD | -103.06% |
2020 Q1 | -9.43 Million USD | 0.0% |
2020 Q3 | 109 Thousand USD | -96.02% |
2019 FY | 9.74 Million USD | 119.97% |
2018 FY | -48.81 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
American Oncology Network, Inc. | -5.54 Million USD | -1159.383% |
Assure Holdings Corp. | -26.07 Million USD | -167.639% |
Novo Integrated Sciences, Inc. | -13.21 Million USD | -428.168% |
Panamera Holdings Corporation | -7.12 Million USD | -879.626% |